Op-Ed: How tech can help keep health care workers safe

guest column

According to a report from National Nurses United, 81.6 percent of nurses said they experienced workplace violence in 2023.

Ask any healthcare worker, and they will have their own story of workplace violence. In the early years of my career, I narrowly missed encountering a gunman in the hospital ER solely because I forgot something and had to return upstairs. While tragedy was avoided in my case, too often, it is not. Such incidents are not isolated; in fact, they are becoming disturbingly common.

According to a report from National Nurses United, 81.6 percent of nurses said they experienced workplace violence in 2023.

As a physician, providing excellent patient care has always been my priority; however, any type of workplace violence disrupts quality care. When the supposedly safe spaces of healing and learning become targets, we must look at ways beyond hardening the exteriors to help prevent such violence within buildings.

For our healthcare systems, the answer may lie within our schools.

Since we lost our daughter and 16 of her classmates and staff at Marjory Stoneman Douglas High School in Parkland, Florida, six years ago, my wife and I have been advocating for enhanced school safety measures for classrooms across the nation.

Seven states have passed Alyssa's Law, named for our daughter, which requires the installation of wearable panic alarm technology in education settings. These alarms, which instantly link every classroom to emergency personnel while also providing mass communication to all staff, serve as a lifeline in times of crisis. These wearable panic alarms are not just outfitted for classrooms: they can be utilized in any workplace setting, including a healthcare system.

Despite their difference in purpose, healthcare facilities and schools share the unique properties of community spaces. Healthcare facilities are safe havens for those who need healing and rest within our community. No one should fear for their safety going to the doctor. Just as lawmakers have rethought and revised school safety requirements, they should do the same for healthcare facilities. Wearable safety technology has emerged as a formidable solution to this pressing issue.

Wearable, mobile duress badge technology is tailor-made for the unique challenges faced by healthcare workers. It is discrete, easy to use, and can be customizable for each healthcare campus. Some duress badge providers have technology that equips nurses, doctors and staff with badges that display their location and the ability to signal the level of emergency with a push of a button. They can use one badge for all campuses within a healthcare system, and they do not have to wait to get in touch with a hospital operator to “sound the alarm” or risk escalating a situation by lunging for a wall-mounted panic button.

Mobile panic alarms offer a nuanced and efficient response mechanism. Whether a minor incident or a life-threatening crisis, healthcare professionals can instantly summon help, ensuring a swifter and more coordinated response.

Texas was one of the first states to take on this alarming trend of workplace violence by passing SB240 last session, mandating facilities to establish a workplace violence prevention plan. Similar legislation is playing out in other states, becoming a nationwide movement.

I know healthcare facilities' budgets are tight these days with unprecedented rising costs of care and lower reimbursement rates. Still, through my personal journey in advocating for safety improvements in our educational institutions, I have learned one thing: you must invest in the future.

The adoption of wearable panic alarms is not just a security upgrade; it's a commitment to the well-being of those who dedicate their lives to provide healing and care. It's about protecting our community spaces. Like any other, the healthcare environment should be a sanctuary, free from the fear of violence. As Alyssa’s Law gains traction nationally, the spotlight now turns to healthcare facilities to embrace this critical technology.

Time, as we know too well, equals life. Swift action can be the difference between tragedy and survival. Investing in wearable panic alarm technology is an investment in our healthcare workforce's safety, resilience, and mental well-being. As we advocate for students to have a safe place to thrive, I am doing the same for healthcare places. The time has come to make our healthcare facilities safe.

------

Dr. Ilan Alhadeff is the father of Alyssa Alhadeff, a victim of the February 14, 2018, school shooting at Marjory Stoneman Douglas High School, and co-founder of Make Our Schools Safe, a 501(c)(3) nonprofit organization dedicated to improving school safety.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston startup debuts bio-based 'leather' fashion collection in Milan

sustainable fashion

Earlier this month, Houston-based Rheom Materials and India’s conscious design studio Econock unveiled a collaborative capsule collection that signaled more than just a product launch.

Hosted at Lineapelle—long considered the global epicenter of the world's premier leather supply chain—in the vaulted exhibition halls of Rho-Fiera Milano, the collection centered around Rheom’s 91 percent bio-based leather alternative, Shorai.

It was a bold move, one that shifted sustainability from a concept discussed in panel sessions to garments that buyers could touch and wear.

The collection featured a bomber-style jacket, an asymmetrical skirt and a suite of accessories—all fabricated from Shorai.

The standout piece, a sculptural jacket featuring a funnel neck and dual-zip closure, was designed for movement, challenging assumptions about performance limitations in bio-based materials. The design of the asymmetrical skirt was drawn from Indian armored warrior traditions, according to Rheom, with biodegradable corozo fasteners.

Built as a modular wardrobe rather than isolated pieces, the collection reflects a shared belief between Rheom and Econock in designing objects that adapt to daily life, according to the companies.

The collection was born out of a new partnership between Rheom and Econock, focused on bringing biobased materials to the market. According to Rheom, the partnership solves a problem that has stalled the adoption of many next-gen textiles: supply chain friction.

While Rheom focuses on engineering scalable bio-based materials, New Delhi-based Econock brings the complementary design and manufacturing ecosystem that integrates artisans, circular materials and production expertise to translate the innovative material into finished goods.

"This partnership removes one of the biggest barriers brands face when adopting next-generation materials,” Megan Beck, Rheom’s director of product, shared in a news release. “By reducing friction across the supply chain, Rheom can connect brands directly with manufacturers who already know how to work with Shorai, making the transition to more sustainable materials far more accessible.”

Sanyam Kapur, advisor of growth and impact at Econock, added: “Our partnership with Rheom Materials represents the benchmark of responsible design where next-gen materials meet craft, creativity, and real-world scalability.”

Rheom, formerly known as Bucha Bio, has developed Shorai, a sustainable leather alternative that can be used for apparel, accessories, car interiors and more; and Benree, an alternative to plastic without the carbon footprint. In 2025, Rheom was a finalist for Startup of the Year in the Houston Innovation Awards.

Shorai is already used by fashion lines like Wuxly and LuckyNelly, according to Rheom. The company scaled production of the sugar-based material last year and says it is now produced in rolls that brands can take to market with the right manufacturer.

Houston startup debuts leather alternative fashion collection in Milan

Houston clean energy co. secures $100M to deploy tech on global scale

Going Global

Houston-based Utility Global has raised $100 million in an ongoing Series D round to globally deploy its decarbonization technology at an industrial scale.

The round was led by Ara Partners and APG Asset, according to a news release. Utility plans to use the funding to expand manufacturing, grow its teams and support its commercial developments and partnerships.

“This financing marks a critical step in Utility’s transition from a proven technology to full-scale global commercial execution,” Parker Meeks, CEO and president of Utility Global, said in the release. “Industrial customers are no longer looking for pilots or promises; they need deployable solutions that work within existing assets and deliver true economic industrial decarbonization today that is operationally reliable and highly scalable. Utility’s technology produces both economic clean hydrogen and capture-ready CO2 streams, and this capital enables us to scale and deploy that impact globally with speed, discipline, and rigor.”

Utility Global's H2Gen technology produces low-cost, clean hydrogen from water and industrial off-gases without requiring electricity. It's designed to integrate into existing industrial infrastructure in hard-to-abate assets in the steel, refining, petrochemical, chemical, low-carbon fuels, and upstream oil and gas sectors.

“Utility is tackling one of the most difficult challenges in the energy transition: decarbonizing hard‑to‑abate industrial sectors,” Cory Steffek, partner at Ara Partners and Utility Global board chair, said in the release. “What sets Utility apart is its ability to compete head‑to‑head with conventional fossil‑based solutions on cost and reliability, even as it materially reduces emissions. With this new funding, Utility is well-positioned for its next chapter of commercial growth while maintaining the technical excellence and capital discipline that have defined its development to date.”

Utility Global reached several major milestones in 2025. After closing a $53 million Series C, the company agreed to develop at least one decarbonization facility at an ArcelorMittal steel plant in Brazil. It also signed a strategic partnership with California-based Kyocera International Inc. to scale global manufacturing of its H2Gen electrochemical cells.

The company also partnered with Maas Energy Works, another California company, to develop a commercial project integrating Maas’ dairy biogas systems with H2Gen to produce economical, clean hydrogen.

"These projects were never intended to stand alone. They anchor a deep and growing pipeline of commercial projects now in development globally across steel, refining, chemicals, biogas and other hard-to-abate sectors worldwide, Meeks shared in a 2025 year-in-review note. He added that 2026 would be a year of "focused acceleration to scale."

---

This article originally appeared on EnergyCapitalHTX.com.

Houston Methodist awarded $4M grant to recruit head of Neal Cancer Center

new hire

Armed with a $4 million state grant, the Houston Methodist Academic Institute has recruited a renowned expert in ovarian and endometrial cancer research to lead the Dr. Mary and Ron Neal Cancer Center.

The grant, provided by the Cancer Prevention and Research Institute of Texas, enabled the institute to lure Dr. Daniela Matei away from Northwestern University’s Feinberg School of Medicine in Chicago. There, she is the Diana Princess of Wales Professor in Cancer Research and chief of the Division of Reproductive Science in Medicine.

Matei will succeed Dr. Jenny Chang, who was hired last year to run the Houston Methodist Academic Institute.

At the Neal Cancer Center, located in the Texas Medical Center complex, oncologists work on innovations in cancer research, treatment, and technology. The center opened in 2021 after the Neals donated $25 million to expand Houston Methodist’s cancer research capabilities. It handles about 7,000 new cases each year involving more than two dozen types of cancer.

U.S. News & World Report puts Houston Methodist Hospital at No. 19 among the country’s best hospitals for cancer care, two spots below Chicago’s Northwestern Memorial Hospital. The University of Texas MD Anderson Cancer Center in Houston sits at No. 1 on the list.

Matei’s research related to ovarian and endometrial cancer holds the potential to benefit tens of thousands of American women. The American Cancer Society estimates:

  • 21,010 women in the U.S. will be diagnosed with ovarian cancer, and 12,450 women will die from it.
  • 68,270 women in the U.S. will be diagnosed with endometrial cancer, and 14,450 women will die from it.

Matei is leaving Northwestern in the wake of widespread cuts in federal funding for medical research. The National Institutes of Health (NIH) has canceled or frozen tens of millions of dollars in grants for Northwestern, the Wall Street Journal reports, and the university has been plugging the gaps with its own money.

“The university is totally keeping us on life support,” Matei told the newspaper last year. “The big question is for how long they can do this.”

According to the Wall Street Journal, Matei’s $5 million NIH grant supporting 69 cancer trials has been caught up in the federal funding chaos, so Northwestern stepped in to cover trial expenses such as nurses’ salaries and diagnostic procedures.

Trial participants include some patients with rare, incurable tumors who are undergoing experimental treatments aligned with the genetics of their condition, the newspaper says.

“It’s certainly a life-and-death situation for cancer patients on these trials,” Matei said in 2025.

Matei is among the beneficiaries of more than $15 million in grants approved February 18 by CPRIT’s board. The grants went toward recruiting five cancer researchers to institutions in Texas.

One of those grants, totaling $1.5 million, went to the University of Houston to recruit Akash Gupta, a research scientist at MIT’s Koch Institute for Integrative Cancer Research. The remaining grants went to recruit scientists to The University of Texas at Dallas and The University of Texas Southwestern Medical Center.
View All Listings